Cannabis Science Inc ( CBIS OTCQB )
Recently these shares have
We feel that with its superior management team in place and
new exciting products coming on line CBIS OTCQB is poised
to move higher
Subscribers and serious investors should place these shares on their
ACTIVE BUY LIST
HR 1841 May Pass House
Ontario to allow private-sector sales of marijuana - Globe &
- TSXV: WMD, OTCQB: WDDMF, FSE:4WE
We feel these shares are undervalued and subscribers should
take note . SeeThru Equity recently placed a C $3.50 target
price on these shares , more than a double from current
levels. Subscribers should place these shares on their
Freedom Leaf Inc. ( FRLF
These shares have more than tripled in the
past 3 months climbing to $0.22 on very high volume . FRLF is worth
watching for any pullback giving our subscribers opportunities to step
up and purchase these shares.
A recent research report on FRLF has been issued by by Wall Street
Research . The report highlights the company's superior editorial team
and products and recommends the purchase of the shares.
Read This Report
We expect these shares to test higher
levels and we place our short term target price at $0.22
Horizons Marijuana Life Sciences
Index ETF (OTC:HMLSF)
Largest cannabis ETF offered in
the market right now. This ETF is listed on the TSX and
holds a basket of North American publicly listed life
sciences companies with significant business activities in
the marijuana industry. The fund was the first cannabis ETF
to enter the market and has delivered impressive returns for
early investors. Current AUM stands at C$726 million.
MARAPHARM VENTURES / MDM TSX.V - MRPHF OTCQX -
Marijuana sales will be in full swing as we write generating
substantial and significant revenues for these companies
with Marapharm leading the way .
Since 2016 MRPHF has rapidly expanded
their footprint to include production locations in the key North
American states of Washington, Nevada,
and California. They actively seek expansion opportunities
worldwide. A superior management team drives this company .
This company has recently
completed a major financing which is reflected in
the usual post financing downward bias of the
shares .Time To Buy !
10 Day Chart